Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-041173

Chief Medical Officer gave up 1,648 shares (to pay taxes)

  • Chief Medical Officer acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gordon David N. Chief Medical Officer 2019-07-02 Option exercise +6,000 6,000 D
Gordon David N. Chief Medical Officer 2019-07-02 Shares withheld for taxes −1,648 $2.34 $3,856 4,352 D
Derivatives
Gordon David N. Chief Medical Officer 2019-07-02 Option exercise · Restricted Stock Units −6,000 18,000 D
Loading xslF345X03/doc4.xml…